An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106)
Chloramphenicol has been studied across 9 research domains including 🫘 Kidney, 🧠 Focus & Attention, 🦠 Gut & Microbiome, 🏋️ Muscle & Hypertrophy, 🫁 Liver & Detox. The primary research focus is 🫘 Kidney with 2% of studies addressing this area.
The following compounds share molecular targets with Chloramphenicol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Chloramphenicol is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.